Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2009
10/20/2009CA2336663C Coumarin and related aromatic-based polymeric prodrugs
10/20/2009CA2290743C Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
10/18/2009CA2662943A1 Inhalative and instillative use of semifluorinated alkanes as an active substance carrier in the intrapulmonary area
10/15/2009WO2009126913A1 Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery
10/15/2009WO2009126805A2 Therapeutic tarageting of mmps in neutral liposomes
10/15/2009WO2009126637A1 Antifolate compositions
10/15/2009WO2009126349A2 Methods and compositions related to internalizing rgd peptides
10/15/2009WO2009126333A1 Oligomer-aryloxy-substituted propanamine conjugates
10/15/2009WO2009126302A2 Stabilized oleosome preparations and methods of making them
10/15/2009WO2009126301A2 Controlled release of active agents from oleosomes
10/15/2009WO2009126145A1 Phosphate-binding chitosan and uses thereof
10/15/2009WO2009125975A2 Combination of mitiglinide and metformin and process for preparing same
10/15/2009WO2009125858A1 Lipid dispersion preparation comprising 2-indolinone derivative
10/15/2009WO2009125816A1 Vesicle and cosmetic containing the same
10/15/2009WO2009125667A1 Water-based adhesive skin patch containing butenafine hydrochloride
10/15/2009WO2009125485A1 Hard capsule
10/15/2009WO2009125483A1 Hard capsule
10/15/2009WO2009125394A1 Anti human immunodeficiency antibodies and uses thereof
10/15/2009WO2009125126A2 Functionalized polysiloxanes, method of preparing same and uses thereof
10/15/2009WO2009124941A2 Trypanocidal compounds targeted to trypanosomes interior
10/15/2009WO2009124586A1 Aqueous pharmaceutical formulation
10/15/2009WO2009124580A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
10/15/2009WO2009124503A1 Use of protein extract from plant seed embryo and composition thereof
10/15/2009WO2009124381A1 An anti-cancer cytotoxic monoclonal antibody
10/15/2009WO2009124357A1 Fast dissolving oral formulations for critical drugs
10/15/2009WO2009105278A3 Nanoparticle targeted drug delivery to the lungs using extra-testicular sertoli cells
10/15/2009WO2009083686A9 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
10/15/2009WO2009077755A3 Latency associated protein construct with aggrecanase sensitive cleavage site
10/15/2009WO2009060473A3 Injectable compositions, processes and uses thereof
10/15/2009WO2009053934A3 Use of metal astringents for the treatment and prevention of hairy heel warts
10/15/2009WO2009053718A3 Immuno-modulatory composition
10/15/2009WO2009050372A3 Compositions containing lipophosphoramides and use thereof in gene therapy
10/15/2009WO2009043926A3 Oral fast disintegrating tablets
10/15/2009WO2008122039A3 Selenocysteine mediated hybrid antibody molecules
10/15/2009US20090258955 Intraocular irrigating solution having improved flow characteristics
10/15/2009US20090258954 Protective hydrocolloid for active ingredients
10/15/2009US20090258953 Use of vinyl acetate-sulfonate copolymers as solubilizers for slightly water-solubable compounds
10/15/2009US20090258952 Patch containing anti-inflammatory agent
10/15/2009US20090258933 Oligonucleotides-transferring preparations
10/15/2009US20090258926 Methods and Compositions for Delivering siRNA into Mammalian Cells
10/15/2009US20090258923 Carrier Composition for Nucleic Acid Transport
10/15/2009US20090258831 Treatment using neublastin polypeptides
10/15/2009US20090258820 Echinocandin/carbohydrate complexes
10/15/2009US20090258171 Antifreeze gel in a deformable container
10/15/2009US20090258071 Compositions and methods for ph targeted drug delivery
10/15/2009US20090258058 Novel silicone film former for delivery of actives
10/15/2009US20090258057 Synthetically Functionalized Living Cells
10/15/2009US20090258039 Method of administering a pharmaceutical active ingredient
10/15/2009US20090258038 Water-soluble compositions of bioactive lipophilic compounds
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090258012 Compositions and methods for treating inflammatory disorders
10/15/2009US20090257975 Solid and Semi-Solid Polymeric Ionic Conjugates
10/15/2009US20090257968 Gels containing anionic surfactants and coupling agents
10/15/2009US20090257960 Neutralized acid group-containing polymers and the use thereof
10/15/2009US20090257950 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
10/15/2009US20090256006 Generation of therapeutic microfoam
10/15/2009DE102008011800A1 Orally disintegrating film, useful e.g. to combat parasites in animals, preferably fish, exotic or wild animals, comprises a matrix made of a polymer of modified pea starch and an antiparasitic agent e.g. ivermectin and selamectin
10/15/2009CA2721183A1 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
10/15/2009CA2721093A1 Human serum albumin linkers and conjugates thereof
10/15/2009CA2721014A1 Aqueous pharmaceutical formulation
10/15/2009CA2720760A1 Oligomer-aryloxy-substituted propanamine conjugates
10/15/2009CA2720756A1 Stabilized oleosome preparations and methods of making them
10/15/2009CA2720755A1 Controlled release of active agents from oleosomes
10/15/2009CA2720748A1 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (dnl) technology
10/15/2009CA2720582A1 Crosslinking method and crosslinked polysaccharide made thereby
10/15/2009CA2719364A1 Butenafine hydrochloride-containing aqueous patch
10/15/2009CA2719295A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
10/15/2009CA2719279A1 Functionalized polysiloxanes, method of preparing same and uses thereof
10/15/2009CA2718330A1 Antifolate compositions
10/14/2009EP2108374A1 Combined meningococcal conjugates with common carrier protein
10/14/2009EP2108368A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker
10/14/2009EP2108362A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound
10/14/2009EP2108359A1 Warming and nonirritating lubricant compositions
10/14/2009EP2107910A2 Polymer-drug conjugates with tether groups for controlled drug delivery
10/14/2009EP1848446B1 Use of iron(iii) complex compounds
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1534339B1 Topical anhydrous and ethanol-free pimecrolimus compositions
10/14/2009EP1423019B1 Process for preparing concentrate thickener compositions
10/14/2009EP1412391B1 Chitosan preparation
10/14/2009EP1331950B1 Ex vivo methods and compositions for nucleic acid delivery
10/14/2009EP1292325B1 Matrix protein compositions for dentin regeneration
10/14/2009EP1232257B1 Modular transport systems for molecular substances and production and use thereof
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009EP0749300B1 Pharmaceutical excipient having improved compressibility
10/14/2009EP0734251B1 Method of transmitting a biologically active material to a cell
10/14/2009CN101557830A Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life
10/14/2009CN101557829A Means and methods of enhancing delivery to biological systems
10/14/2009CN101557828A Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
10/14/2009CN101557827A Pharmaceutical compositions comprising HGH for oral delivery
10/14/2009CN101557804A Phenylalkylamino carbamate compositions
10/14/2009CN101557801A Hydrogels containing low molecular weight alginates and biostructures made therefrom
10/14/2009CN101557718A Process for obtaining leguminous protein fractions of moderate molecular weight, leguminous protein fractions and use thereof
10/14/2009CN101555482A Fusion protein of human parathyrine (1-34) diad and human seralbumin and preparation thereof
10/14/2009CN101555273A Ligand polypeptide combined with Tie2 protein specificity and drug delivery system
10/14/2009CN101555253A Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof
10/14/2009CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof
10/14/2009CN101554574A Superparamagnetism nano particle jointly modified by aminosilane coupling agent and hyskon and preparation method thereof
10/14/2009CN101554480A Improved DNA vaccines for production-type animals
10/14/2009CN101554479A Pharmaceutical composition containing an iron-binding agent
10/14/2009CN101554478A Polycation nano-lipid carrier system and preparation method thereof
1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 1712